BioRestorative Therapies (BRTX) Competitor Comparison
We are evaluating the key criteria listed to compare BioRestorative Therapies (BRTX) against its competitors in the Biotechnology industry.
Market Capitalization
349 / 368Gross Profits
145 / 278Total Revenue
272 / 300EBITDA
69 / 337Free Cashflow
41 / 352Quick Ratio
56 / 357Earnings per Share
119 / 359Dividend yield
0 / 6Total Cash
316 / 358Performance 3 years
237 / 368Performance 5 years
358 / 368Performance 10 years
364 / 368Linearity 3 years
177 / 368Linearity 5 years
326 / 368Linearity 10 years
265 / 368Total Rank
254 / 368Dividend Rank
65 / 368Valuation Rank
189 / 368Piotroski Rank
168 / 368Muliplier Rank
66 / 368EBITDA - BRTX ranking 69 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.